Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) reported an increase of 7.09% in shares shorted. It was published in February by FINRA the 630,200 shares shorted on DFFN. The up change of 7.09% from 588,500 shares was reported. 4 days will cost DFFN with 142,800 average volume to recover its former position.

Ticker’s shares touched $3.13 during the last trading session after 0.97% change.Diffusion Pharmaceuticals Inc. has volume of 80,128 shares. Since February 27, 2018 DFFN has declined 85.50% and is downtrending. DFFN underperformed by 85.50% the S&P500.

Diffusion Pharmaceuticals Inc., a clinical-stage biotechnology company, developing small-molecule drugs that help regulate the movement of oxygen into tissue by a novel mechanism of action.The firm is worth $10.57 million. The Company’s lead product candidate is trans sodium crocetinate, which is in Phase I/II clinical trials for the treatment of glioblastoma multiforme ; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II/III clinical trials for the treatment of metastatic brain cancer.Last it reported negative earnings. The firm is also developing RES-529, a novel PI3K/Akt/mTOR pathway inhibitor, which has completed two Phase I clinical trials for the treatment of macular degeneration; and is in pre-clinical development in oncology applications primarily GBM.

For more Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) news announced recently go to: Benzinga.com, Nasdaq.com, Seekingalpha.com, Globenewswire.com or Benzinga.com. The titles are as follows: “56 Biggest Movers From Yesterday – Benzinga” announced on February 05, 2019, “Poster Presented at International Stroke Conference Describing Diffusion’s On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke – Nasdaq” on February 11, 2019, “Diffusion Pharma executes 1:15 reverse split – Seeking Alpha” with a publish date: December 14, 2018, “Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market – GlobeNewswire” and the last “35 Stocks Moving In Monday’s Mid-Day Session – Benzinga” with publication date: February 04, 2019.